Boehringer Ingelheim S.A. de C.V.

The Contract Manufacturing Market Revenues Is Forecast To Reach Approximate Value of $44 Billion By 2015.
M2 Presswire; 12/8/2009; 970 words; ...of $44 Billion By 2015(C)1994-2009 M2 COMMUNICATIONS...assist Pharma manufacturer's right from clinical trials...Organosys - Royal DSM N.V. - Evonik - Patheon - Fareva - Cambrex - Boehringer Ingelheim For more information visit...

Central Nervous System Therapeutics - A Comprehensive World Market Review of Geographic Coverage and Vertical Market Analysis.
M2 Presswire; 11/19/2009; 749 words; ...Market Analysis(C)1994-2009 M2...reverse the disease's progression. Continuing...AstraZeneca Plc (UK) - Boehringer Ingelheim GmbH (Germany...Pharmaceutica N.V. (Belgium...Pharmaceuticals S.A. (Belgium...Israel) - UCB S.A. (Belgium...

Netherlands Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015.
M2 Presswire; 10/13/2009; 672 words; ...and Forecasts to 2015(C)1994-2009 M2 COMMUNICATIONS...Global Markets Direct's new report "Netherlands...Cardinal Health, Inc. - Boehringer Ingelheim GmbH - Consort Medical...AstraZeneca PLC - Medisize B.V. For more information...

Short Sale Recap. Highest % Of Daily Trading Volume Short All Exchanges Combined For Thursday.
M2 Presswire; 9/25/2009; 3290 words; ...For Thursday(C)1994-2009 M2...introducing brokers and (v) continues to...satisfy Rule 204's close-out requirement...clearing broker's fail position was...and hepatitis C virus (HCV) infections...BioPharma, Inc.; Boehringer Ingelheim International GmbH...

2E Coagulation disorders.(SECTION 2: CARDIOVASCULAR SYSTEM)(Drug overview)
Residents' Prescribing Reference; 9/22/2009; 2289 words; AGGRENOX Boehringer Ingelheim Rx Combination antiplatelet. Dipyridamole...avoid in neonates. Pregnancy (Cat.C). Interactions: Potentiated by anticoagulants...usual max 12.5 days). STEMI: 30mg V bolus plus 1mg/kg SC dose, then 1mg...